[144] Bausch Health Companies Inc SEC Filing
Bausch Health Companies Inc (BHC) filed a Form 144 reporting a proposed sale of 15,912 common shares valued at $121,887.71. The shares were acquired on 05/12/2025 through restricted stock vesting as compensation from the issuer. The filer lists an approximate sale date of 08/21/2025 and the broker named is Fidelity Brokerage Services LLC with execution on the NYSE. The filing states there were 369,790,319 shares outstanding at the time and reports no securities sold by the filer in the prior three months. The notice includes the standard insider representation regarding absence of undisclosed material adverse information.
Bausch Health Companies Inc (BHC) ha depositato un Modulo 144 segnalando la proposta vendita di 15.912 azioni ordinarie per un valore di $121.887,71. Le azioni sono state acquisite il 12/05/2025 tramite vesting di azioni soggette a restrizioni come compenso dall'emittente. Il dichiarante indica una data di vendita approssimativa del 21/08/2025 e il broker nominato 猫 Fidelity Brokerage Services LLC con esecuzione sul NYSE. Il deposito riporta che al momento vi erano 369.790.319 azioni in circolazione e che il dichiarante non ha venduto titoli nei tre mesi precedenti. L'avviso include la consueta dichiarazione dell'insider relativa all'assenza di informazioni materiali avverse non divulgate.
Bausch Health Companies Inc (BHC) present贸 un Formulario 144 informando sobre una propuesta de venta de 15.912 acciones comunes por un valor de $121.887,71. Las acciones fueron adquiridas el 12/05/2025 mediante vesting de acciones restringidas como compensaci贸n del emisor. El declarante indica una fecha de venta aproximada del 21/08/2025 y el corredor nombrado es Fidelity Brokerage Services LLC, con ejecuci贸n en la NYSE. La presentaci贸n se帽ala que hab铆a 369.790.319 acciones en circulaci贸n en ese momento y que el declarante no vendi贸 valores en los tres meses anteriores. El aviso incluye la representaci贸n est谩ndar del insider sobre la ausencia de informaci贸n adversa material no divulgada.
Bausch Health Companies Inc (BHC)臧� 鞝滌晥霅� 毵る弰 雮挫毄鞚� 氤搓碃頃橂姅 Form 144鞚� 鞝滌稖頄堨姷雼堧嫟. 鞝滌晥霅� 毵る弰電� 15,912 氤错喌欤茧 臧�旃橂姅 $121,887.71鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 2025-05-12鞐� 氚滍枆須岇偓搿滊秬韯� 氤挫儊鞙茧 氚涭潃 鞝滍暅欤�(毽姢韸鸽Ν韹半摐 鞀ろ啞) 氩犾姢韺�鞚� 韱淀暣 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖鞚胳潃 雽�霝奠爜鞚� 毵り皝鞚检潉 2025-08-21搿� 旮办灛頄堦碃, 歆�鞝� 欷戧皽鞚胳潃 Fidelity Brokerage Services LLC鞚措┌ 瓯半灅電� NYSE鞐愳劀 鞚措（鞏挫雼堧嫟. 鞝滌稖靹滌棎電� 雼轨嫓 鞙犿喌欤检嫕靾橂姅 369,790,319欤检榾瓿�, 鞝滌稖鞚胳潃 斓滉芳 3臧滌洈臧� 鞙犼皜歃濌秾鞚� 毵る弰頃橃 鞎婌晿雼り碃 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 韱奠氍胳棎電� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗠嫟電� 雮措秬鞛� 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Bausch Health Companies Inc (BHC) a d茅pos茅 un formulaire 144 signalant une proposition de vente de 15 912 actions ordinaires pour une valeur de 121 887,71 $. Les actions ont 茅t茅 acquises le 12/05/2025 via le vesting d'actions restreintes en tant que r茅mun茅ration de l'茅metteur. Le d茅clarant indique une date de vente approximative au 21/08/2025 et le courtier nomm茅 est Fidelity Brokerage Services LLC, l'ex茅cution se fera sur la NYSE. Le d茅p么t pr茅cise qu'il y avait 369 790 319 actions en circulation 脿 ce moment-l脿 et que le d茅clarant n'a pas vendu de titres au cours des trois mois pr茅c茅dents. L'avis comprend la repr茅sentation habituelle de l'initi茅 concernant l'absence d'informations d茅favorables mat茅rielles non divulgu茅es.
Bausch Health Companies Inc (BHC) hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 15.912 Stammaktien im Wert von $121.887,71 gemeldet wird. Die Aktien wurden am 12.05.2025 im Rahmen der Vesting von eingeschr盲nkten Aktien als Verg眉tung des Emittenten erworben. Der Einreicher nennt ein ungef盲hres Verkaufsdatum vom 21.08.2025 und als benannten Broker Fidelity Brokerage Services LLC, die Ausf眉hrung erfolgt an der NYSE. Die Meldung gibt an, dass zum Zeitpunkt 369.790.319 Aktien ausstanden und dass der Einreicher in den vorangegangenen drei Monaten keine Wertpapiere verkauft hat. Die Bekanntmachung enth盲lt zudem die 眉bliche Insidererkl盲rung 眉ber das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen.
- Timely regulatory disclosure: The filer submitted a Form 144 identifying the shares to be sold and broker details.
- Securities originated from compensation: The 15,912 shares were acquired through restricted stock vesting on 05/12/2025, not from an external purchase.
- Planned insider sale: The filer intends to sell 15,912 common shares with an approximate sale date of 08/21/2025.
- No trading plan date disclosed: The filing does not indicate adoption of a Rule 10b5-1 trading plan or provide a plan adoption date.
Insights
TL;DR: Insider plans to sell recently vested restricted shares worth ~$122k, disclosed under Rule 144 for public execution.
This Form 144 reports a routine compliance disclosure: 15,912 shares from restricted stock vesting will be offered for sale using Fidelity as broker on the NYSE with an approximate date of 08/21/2025. The reported aggregate market value is $121,887.71 and the issuer's outstanding shares are listed as 369,790,319. There are no reported sales by the filer in the prior three months. From a trading-impact perspective, the transaction size is modest relative to typical company floats; the filing fulfills regulatory notice requirements without indicating other material events.
TL;DR: Disclosure aligns with governance and insider-trading rules; filer affirms no undisclosed material information.
The filing documents that the shares were acquired as compensation via restricted stock vesting on 05/12/2025 and that the filer executed the statutory attestation regarding material information. The inclusion of broker details and the absence of prior sales in the last three months indicate adherence to Rule 144 aggregation and reporting norms. The notice does not disclose any trading plan date or other governance actions beyond the standard representation.
Bausch Health Companies Inc (BHC) ha depositato un Modulo 144 segnalando la proposta vendita di 15.912 azioni ordinarie per un valore di $121.887,71. Le azioni sono state acquisite il 12/05/2025 tramite vesting di azioni soggette a restrizioni come compenso dall'emittente. Il dichiarante indica una data di vendita approssimativa del 21/08/2025 e il broker nominato 猫 Fidelity Brokerage Services LLC con esecuzione sul NYSE. Il deposito riporta che al momento vi erano 369.790.319 azioni in circolazione e che il dichiarante non ha venduto titoli nei tre mesi precedenti. L'avviso include la consueta dichiarazione dell'insider relativa all'assenza di informazioni materiali avverse non divulgate.
Bausch Health Companies Inc (BHC) present贸 un Formulario 144 informando sobre una propuesta de venta de 15.912 acciones comunes por un valor de $121.887,71. Las acciones fueron adquiridas el 12/05/2025 mediante vesting de acciones restringidas como compensaci贸n del emisor. El declarante indica una fecha de venta aproximada del 21/08/2025 y el corredor nombrado es Fidelity Brokerage Services LLC, con ejecuci贸n en la NYSE. La presentaci贸n se帽ala que hab铆a 369.790.319 acciones en circulaci贸n en ese momento y que el declarante no vendi贸 valores en los tres meses anteriores. El aviso incluye la representaci贸n est谩ndar del insider sobre la ausencia de informaci贸n adversa material no divulgada.
Bausch Health Companies Inc (BHC)臧� 鞝滌晥霅� 毵る弰 雮挫毄鞚� 氤搓碃頃橂姅 Form 144鞚� 鞝滌稖頄堨姷雼堧嫟. 鞝滌晥霅� 毵る弰電� 15,912 氤错喌欤茧 臧�旃橂姅 $121,887.71鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 2025-05-12鞐� 氚滍枆須岇偓搿滊秬韯� 氤挫儊鞙茧 氚涭潃 鞝滍暅欤�(毽姢韸鸽Ν韹半摐 鞀ろ啞) 氩犾姢韺�鞚� 韱淀暣 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖鞚胳潃 雽�霝奠爜鞚� 毵り皝鞚检潉 2025-08-21搿� 旮办灛頄堦碃, 歆�鞝� 欷戧皽鞚胳潃 Fidelity Brokerage Services LLC鞚措┌ 瓯半灅電� NYSE鞐愳劀 鞚措（鞏挫雼堧嫟. 鞝滌稖靹滌棎電� 雼轨嫓 鞙犿喌欤检嫕靾橂姅 369,790,319欤检榾瓿�, 鞝滌稖鞚胳潃 斓滉芳 3臧滌洈臧� 鞙犼皜歃濌秾鞚� 毵る弰頃橃 鞎婌晿雼り碃 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 韱奠氍胳棎電� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗠嫟電� 雮措秬鞛� 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Bausch Health Companies Inc (BHC) a d茅pos茅 un formulaire 144 signalant une proposition de vente de 15 912 actions ordinaires pour une valeur de 121 887,71 $. Les actions ont 茅t茅 acquises le 12/05/2025 via le vesting d'actions restreintes en tant que r茅mun茅ration de l'茅metteur. Le d茅clarant indique une date de vente approximative au 21/08/2025 et le courtier nomm茅 est Fidelity Brokerage Services LLC, l'ex茅cution se fera sur la NYSE. Le d茅p么t pr茅cise qu'il y avait 369 790 319 actions en circulation 脿 ce moment-l脿 et que le d茅clarant n'a pas vendu de titres au cours des trois mois pr茅c茅dents. L'avis comprend la repr茅sentation habituelle de l'initi茅 concernant l'absence d'informations d茅favorables mat茅rielles non divulgu茅es.
Bausch Health Companies Inc (BHC) hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 15.912 Stammaktien im Wert von $121.887,71 gemeldet wird. Die Aktien wurden am 12.05.2025 im Rahmen der Vesting von eingeschr盲nkten Aktien als Verg眉tung des Emittenten erworben. Der Einreicher nennt ein ungef盲hres Verkaufsdatum vom 21.08.2025 und als benannten Broker Fidelity Brokerage Services LLC, die Ausf眉hrung erfolgt an der NYSE. Die Meldung gibt an, dass zum Zeitpunkt 369.790.319 Aktien ausstanden und dass der Einreicher in den vorangegangenen drei Monaten keine Wertpapiere verkauft hat. Die Bekanntmachung enth盲lt zudem die 眉bliche Insidererkl盲rung 眉ber das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen.
FAQ
What does the BHC Form 144 report?
When is the approximate sale date listed on the BHC Form 144?
Which broker is named for the proposed BHC share sale?
How many BHC shares were outstanding according to the filing?
Did the filer sell any BHC securities in the past three months?
How were the shares acquired by the filer?
